Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Showing 20 of 0 results

Very early researchStudy completedNCT05551624
What this trial is testing

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Who this might be right for
Primary Immune Thrombocytopenia
Hospital Civil de Guadalajara 15
Testing effectiveness (Phase 2)UnknownNCT03304288
What this trial is testing

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT05885555
What this trial is testing

Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 41
Large-scale testing (Phase 3)Study completedNCT05029635
What this trial is testing

Phase III Study on HMPL-523 for Treatment of ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Hutchmed 272
Testing effectiveness (Phase 2)UnknownNCT05471050
What this trial is testing

The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 120
Large-scale testing (Phase 3)Study completedNCT03164915
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
SK Plasma Co., Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT06799611
What this trial is testing

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)Treatment
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)UnknownNCT03177629
What this trial is testing

H. Pylori Eradication for Moderate ITP

Who this might be right for
Immune Thrombocytopenic PurpuraHelicobacter PyloriImmune Thrombocytopenia
Seoul National University Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00424177
What this trial is testing

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 66
Testing effectiveness (Phase 2)UnknownNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Large-scale testing (Phase 3)UnknownNCT02877212
What this trial is testing

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Post-approval studies (Phase 4)Study completedNCT02760251
What this trial is testing

Immunomodulation With Romiplostim in Young Adults With ITP

Who this might be right for
Immune Thrombocytopenia
University Hospital, Basel, Switzerland 15
Post-approval studies (Phase 4)UnknownNCT03172676
What this trial is testing

Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Assiut University 75
Not applicableLooking for participantsNCT02877706
What this trial is testing

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
University Hospital, Toulouse 1,500
Large-scale testing (Phase 3)Study completedNCT00168038
What this trial is testing

Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Who this might be right for
Immune Thrombocytopenic Purpura
CSL Behring 58
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Not applicableLooking for participantsNCT07786077
What this trial is testing

Patients' Preferences for Primary Immune Thrombocytopenia Treatment

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 100
Not applicableStudy completedNCT03154385
What this trial is testing

Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 15
Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation